Share on StockTwits
 

Tearlab Corporation (NASDAQ:TEAR) Director Richard Lindstrom sold 5,000 shares of the company’s stock on the open market in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $9.26, for a total transaction of $46,300.00. Following the transaction, the director now directly owns 86,238 shares of the company’s stock, valued at approximately $798,564. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Tearlab Corporation (NASDAQ:TEAR) traded up 5.78% during mid-day trading on Thursday, hitting $9.88. 535,448 shares of the company’s stock traded hands. Tearlab Corporation has a 52 week low of $4.11 and a 52 week high of $15.18. The stock’s 50-day moving average is $9.11 and its 200-day moving average is $11.17. The company’s market cap is $327.2 million.

Tearlab Corporation (NASDAQ:TEAR) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.14) by $0.01. The company had revenue of $4.20 million for the quarter, compared to the consensus estimate of $3.80 million.

TearLab Corp., formerly OccuLogix, Inc, is an in-vitro diagnostic company based in San Diego, California.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.